Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion
Clinical trial NCT05532735 · COMPLETED
Trial details
- NCT number
- NCT05532735
- Sponsor
- Annexin Pharmaceuticals AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-24
- Primary completion
- 2024-07-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.